Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM167A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARFGAP3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NUS1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RSL24D1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
METAP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TM2D1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SSR2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARF4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CCNT2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RAD23B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DDX21 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PSMA7 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CAND1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CAAP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DPH5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATG5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TGDS - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ORC4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FEM1B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on